Xilio Therapeutics annual net debt
2020
2021
2022
2023
2024
2025
Xilio Therapeutics Net Debt Growth & History (XLO)
Xilio Therapeutics's net debt was −$130.6M for fiscal 2025.
View full Xilio Therapeutics company overviewXilio Therapeutics annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$130.6M | −$83.4M | — |
| 2024 | 2024-12-31 | −$47.1M | −$11.7M | — |
| 2023 | 2023-12-31 | −$35.5M | $74.7M | — |
| 2022 | 2022-12-31 | −$110.2M | $76.8M | — |
| 2021 | 2021-12-31 | −$186.9M | −$179.4M | — |
| 2020 | 2020-12-31 | −$7.5M | — | — |
Xilio Therapeutics quarterly net debt
Q4.20
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$129.7M | −$15.8M | — |
| Q1 2026 | 2026-03-31 | −$143.7M | −$62.5M | — |
| Q4 2025 | 2025-12-31 | −$130.6M | −$83.4M | — |
| Q3 2025 | 2025-09-30 | −$96.5M | −$43.7M | — |
| Q2 2025 | 2025-06-30 | −$114.0M | −$47.7M | — |
| Q1 2025 | 2025-03-31 | −$81.2M | −$56.2M | — |
| Q4 2024 | 2024-12-31 | −$47.1M | −$11.7M | — |
| Q3 2024 | 2024-09-30 | −$52.8M | −$2.5M | — |
| Q2 2024 | 2024-06-30 | −$66.3M | −$547,000 | — |
| Q1 2024 | 2024-03-31 | −$25.0M | $58.3M | — |
| Q4 2023 | 2023-12-31 | −$35.5M | $74.7M | — |
| Q3 2023 | 2023-09-30 | −$50.3M | $78.5M | — |
| Q2 2023 | 2023-06-30 | −$65.7M | $83.2M | — |
| Q1 2023 | 2023-03-31 | −$83.4M | $82.9M | — |
| Q4 2022 | 2022-12-31 | −$110.2M | $76.8M | — |
| Q3 2022 | 2022-09-30 | −$128.8M | −$40.1M | — |
| Q2 2022 | 2022-06-30 | −$148.9M | — | — |
| Q1 2022 | 2022-03-31 | −$166.2M | — | — |
| Q4 2021 | 2021-12-31 | −$186.9M | −$179.4M | — |
| Q3 2021 | 2021-09-30 | −$88.7M | — | — |
| Q4 2020 | 2020-12-31 | −$7.5M | — | — |
Xilio Therapeutics net debt trends
Over the last five fiscal years, Xilio Therapeutics's net debt decreased from −$7.5M to −$130.6M, a change of −$123.1M. The latest reported quarter, Q2 2026, shows −$129.7M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Xilio Therapeutics source filings ↗